Biotech · Private company · Cambridge, MA, US

Vincere Biosciences, Inc.

Track this companyFree. Adds Vincere Biosciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

IND-enabling studies of a USP30 inhibitor for acute kidney injuryFiscal year 2026 · $1.3MNIH RePORTER 1R44DK143820-01A1 · fetched Nov 12, 2026
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's DiseaseFiscal year 2024 · $228.7KNIH RePORTER 5R43NS127693-02 · fetched Nov 12, 2026